US Patent 9994522 Amorphous form of apremilast
Patent 9994522 was granted and assigned to Mapi Pharma on June, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9994522 Amorphous form of apremilast
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.